Concepedia

Maria Themeli

MT

Statistics

Publications

24

Citations

2.5K

H-Index

17

Active since

2010

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

Amsterdam University Medical Centers

Queen Mary University of London

Vrije Universiteit Amsterdam

Memorial Sloan Kettering Cancer Center

Maria Themeli is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2010–2024

24

Publications

24

PD-1– and CTLA-4–Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses

V D Fedorov, Maria Themeli, Michel Sadelain · Science Translational Medicine · 2013 · 708 citations

Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy

Maria Themeli, Christopher C. Kloss, Giovanni Ciriello et al. · Nature Biotechnology · 2013 · 450 citations · Full text

, , +12

A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization

Esther Drent, Maria Themeli, Renée Poels et al. · Molecular Therapy · 2017 · 285 citations · Full text

, , +9

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

Esther Drent, Richard W.J. Groen, Willy A. Noort et al. · Haematologica · 2016 · 196 citations · Full text

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells

Esther Drent, Renée Poels, Ruud Ruiter et al. · Clinical Cancer Research · 2019 · 168 citations · Full text

1–5 of 24